REPORTS
Plant Biostimulants
OVERVIEW
The global biostimulants market is at an inflection point. What was once a niche category is now becoming the fourth pillar of modern agriculture, sitting alongside genetics, fertilizers, and crop rotation as an essential tool for climate-resilient food production.
The market is already worth $4.2-4.5 billion and growing at roughly 10% annually. Europe is leading in regulatory clarity and premiums while North America is scaling fast as biostimulants integrate into conventional programs. Innovation is shifting from broad spectrum microbials toward defined, standardized actives, particularly single molecule biostimulants that offer repeatable performance.
For investors, innovators, and corporations trying to navigate this sector of the industry, the content quality can be brutal. There are 230+ companies in the space with fragmented regulatory environments, and a legacy of overpromising that’s left them skeptical.
This report cuts through the noise.
WHAT'S INSIDE?
We mapped the entire technology landscape – 64 focused portfolio companies, 299 characterized technologies and 10 years of investment data– to deliver the clearest view of where the biostimulants sector is headed and which platforms are poised to land on top.
The centerpiece is the Accumont Quartile– our proprietary framework that separates Technology Leadership from Company Performance. This acts as a decision making tool that shows you which companies have the strongest tech, which have true market traction, and where those two factors intersect to create compelling opportunities.
Report Pricing
Single-User Licence
$3,000 USD
(corporations of 100 or more employees)